OraQuick
OraQuick
OraQuick (/ɔːrəkwɪk/) is a rapid HIV diagnostic test that provides results in 20-40 minutes. It is the first FDA-approved oral fluid HIV test, which does not require blood samples or laboratory analysis.
Etymology
The term "OraQuick" is a combination of "oral," referring to the method of testing, and "quick," indicating the speed at which results are obtained.
Description
The OraQuick test uses oral fluid to detect antibodies to HIV-1 and HIV-2, the two types of Human Immunodeficiency Virus. The test is non-invasive and simple to use, making it a popular choice for rapid HIV testing in both clinical and non-clinical settings.
Procedure
To perform the OraQuick test, an individual swabs the device around the outer gums, collecting an oral fluid sample. The device is then inserted into a vial containing a developer solution. After 20-40 minutes, the results can be read directly from the device.
Interpretation of Results
A positive result on the OraQuick test indicates that HIV antibodies have been detected in the oral fluid sample. This is not a diagnosis of HIV infection, but it does suggest that additional testing is necessary to confirm the result. A negative result means that no HIV antibodies were detected. However, this does not rule out the possibility of HIV infection, particularly in individuals who have recently been exposed to the virus.
Related Terms
External links
- Medical encyclopedia article on OraQuick
- Wikipedia's article - OraQuick
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski